These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8385916

  • 21. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM, Mauser A, Swenson J, Davis MG, Talarico CL, Kenney SC.
    Cancer Res; 1999 Apr 01; 59(7):1485-91. PubMed ID: 10197618
    [Abstract] [Full Text] [Related]

  • 22. Lytic cycle gene regulation of Epstein-Barr virus.
    Amon W, Binné UK, Bryant H, Jenkins PJ, Karstegl CE, Farrell PJ.
    J Virol; 2004 Dec 01; 78(24):13460-9. PubMed ID: 15564457
    [Abstract] [Full Text] [Related]

  • 23. A concatenated form of Epstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with BZLF1.
    Cho MS, Tran VM.
    Virology; 1993 Jun 01; 194(2):838-42. PubMed ID: 8389085
    [Abstract] [Full Text] [Related]

  • 24. A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator.
    Sarisky RT, Gao Z, Lieberman PM, Fixman ED, Hayward GS, Hayward SD.
    J Virol; 1996 Dec 01; 70(12):8340-7. PubMed ID: 8970953
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.
    Huang J, Liao G, Chen H, Wu FY, Hutt-Fletcher L, Hayward GS, Hayward SD.
    J Virol; 2006 Feb 01; 80(3):1098-109. PubMed ID: 16414987
    [Abstract] [Full Text] [Related]

  • 28. The position of the ZEBRA activation domain does not influence its biological activity.
    Asković S, Taylor W, Baumann R.
    Virus Res; 1998 Oct 01; 57(2):125-38. PubMed ID: 9870581
    [Abstract] [Full Text] [Related]

  • 29. Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents.
    Rodriguez A, Jung EJ, Flemington EK.
    J Virol; 2001 May 01; 75(10):4482-9. PubMed ID: 11312318
    [Abstract] [Full Text] [Related]

  • 30. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W, Iwakiri D, Yamamoto K, Maruo S, Kanda T, Takada K.
    J Virol; 2007 Jan 01; 81(2):1037-42. PubMed ID: 17079287
    [Abstract] [Full Text] [Related]

  • 31. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.
    Kudoh A, Fujita M, Kiyono T, Kuzushima K, Sugaya Y, Izuta S, Nishiyama Y, Tsurumi T.
    J Virol; 2003 Jan 01; 77(2):851-61. PubMed ID: 12502801
    [Abstract] [Full Text] [Related]

  • 32. A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication.
    Wang P, Day L, Dheekollu J, Lieberman PM.
    J Virol; 2005 Nov 01; 79(21):13298-309. PubMed ID: 16227252
    [Abstract] [Full Text] [Related]

  • 33. The lytic origin of herpesvirus papio is highly homologous to Epstein-Barr virus ori-Lyt: evolutionary conservation of transcriptional activation and replication signals.
    Ryon JJ, Fixman ED, Houchens C, Zong J, Lieberman PM, Chang YN, Hayward GS, Hayward SD.
    J Virol; 1993 Jul 01; 67(7):4006-16. PubMed ID: 8389916
    [Abstract] [Full Text] [Related]

  • 34. Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta: implications for therapy of EBV associated tumors.
    Chen C, Li D, Guo N.
    Cancer Biol Ther; 2009 Jun 01; 8(11):987-95. PubMed ID: 19448399
    [Abstract] [Full Text] [Related]

  • 35. Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1.
    Schwarzmann F, Prang N, Reichelt B, Rinkes B, Haist S, Marschall M, Wolf H.
    J Gen Virol; 1994 Aug 01; 75 ( Pt 8)():1999-2006. PubMed ID: 8046403
    [Abstract] [Full Text] [Related]

  • 36. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L.
    Adv Cancer Res; 2007 Aug 01; 97():81-109. PubMed ID: 17419942
    [Abstract] [Full Text] [Related]

  • 37. Induction of Epstein-Barr virus lytic replication by recombinant adenoviruses expressing the zebra gene with EBV specific promoters.
    Chen L, Yin J, Chen Y, Zhong J.
    Acta Biochim Biophys Sin (Shanghai); 2005 Apr 01; 37(4):215-20. PubMed ID: 15806286
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Latent and lytic Epstein-Barr virus replication strategies.
    Tsurumi T, Fujita M, Kudoh A.
    Rev Med Virol; 2005 Apr 01; 15(1):3-15. PubMed ID: 15386591
    [Abstract] [Full Text] [Related]

  • 40. Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.
    Hsu M, Wu SY, Chang SS, Su IJ, Tsai CH, Lai SJ, Shiau AL, Takada K, Chang Y.
    J Virol; 2008 Apr 01; 82(7):3679-88. PubMed ID: 18234802
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.